Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

Stock Information for Therma Bright Inc.

Loading

Please wait while we load your information from QuoteMedia.